Harmony Biosciences to be Added to the S&P SmallCap 600® Index
10/21/2021 - 08:05 AM
PLYMOUTH MEETING, Pa. , Oct. 21, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it will be added to the S&P SmallCap 600® Index, effective prior to the open of trading on Friday, October 22, 2021 .
"We are very pleased that Harmony will be included in the S&P SmallCap 600® Index and are proud of this recognition," said John C. Jacobs , President and Chief Executive Officer of Harmony. "We believe the inclusion in the index will increase our visibility and raise awareness of the work we are doing to help patients, as we continue to build a leading rare neurological disease company."
The S&P 600® seeks to measure the small-cap segment of the U.S. equity market. The index is designed to measure the performance of 600 small-cap companies in the U.S. reflecting this market segment's distinctive risk and return characteristics. To be included, companies must have an unadjusted market cap in the range of $850 million $3.6 billion
About Harmony Biosciences Harmony Biosciences is a commercial stage pharmaceutical company headquartered in Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare neurological diseases who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com .
Harmony Biosciences Investor Contact: Patti Bank ir@harmonybiosciences.com
Harmony Biosciences Media Contact: Nancy Leone nleone@harmonybiosciences.com
https://www.prnewswire.com/news-releases/harmony-biosciences-to-be-added-to-the-sp-smallcap-600-index-301405226.html
SOURCE Harmony Biosciences
Harmony Biosciences Holdings Inc
HRMY Rankings
#4980 Ranked by Stock Gains
HRMY Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major, Manufacturing, Medicinal and Botanical Manufacturing
About HRMY
patients are at the beginning, middle, and heart of all we do. harmony biosciences, llc, is a privately-owned biopharmaceutical company. the company was established in october 2017 with a vision to provide novel treatment options for people living with rare and orphan diseases with an emphasis on central nervous system disorders, starting with a focus on helping patients who live with narcolepsy. harmony biosciences is committed to advancing the understanding of narcolepsy and providing information and resources to individuals who live with, and healthcare professionals who treat, patients with narcolepsy.
